Spinoff Odds & Ends: New Activist At Shire $SHPG, RBR Raising Money To Fight $CS
In this edition, we provide a few updates to some of our recent articles focusing on activist activities: 1) Sachem Head vs. Shire Pharmaceuticals (SHPG) Shire Pharmaceuticals announced this summer that it was considering its ‘strategic options’, including a potential spinoff, for its neuroscience division in order to better focus on its rare diseases business. Unfortunately, the company’s stock has… Read More »